Search Tag: cervical cancer
2024 10 Nov
Cervical cancer remains a prominent health challenge worldwide, particularly in its advanced stages, where prognosis is generally poor despite the widespread use of combined chemoradiotherapy. As a fourth leading cause of cancer among women globally, locally advanced cervical cancer sees high rates of recurrence and metastasis even after initial...Read more
2024 11 Jul
Cervical cancer remains a significant health challenge globally, particularly in low- and middle-income countries. Nearly all cases of cervical cancer are linked to high-risk human papillomavirus (HPV), a virus transmitted through sexual contact. Despite advancements in screening and vaccination, disparities in access to these preventive measures...Read more
2024 11 Jul
Cervical cancer remains a significant health challenge globally, particularly in low- and middle-income countries. Nearly all cases of cervical cancer are linked to high-risk human papillomavirus (HPV), a virus transmitted through sexual contact. Despite advancements in screening and vaccination, disparities in access to these preventive measures...Read more
2024 13 Feb
Cervical cancer ranks as the fourth most common cancer among women worldwide, with significant morbidity and mortality rates. A key determinant of prognosis and treatment decisions in cervical cancer is the presence of lymph node involvement. The revised staging system by the International Federation of Gynaecology and Obstetrics (FIGO) in 2018...Read more
2024 13 Feb
Cervical cancer ranks as the fourth most common cancer among women worldwide, with significant morbidity and mortality rates. A key determinant of prognosis and treatment decisions in cervical cancer is the presence of lymph node involvement. The revised staging system by the International Federation of Gynaecology and Obstetrics (FIGO) in 2018...Read more
2024 25 Jan
Cervical cancer was once a leading cause of cancer death for women in the United States. Today, screening and prevention have greatly reduced the impact of this form of cancer. Still, approximately 13,960 women in the United States are projected to receive a diagnosis of cervical cancer in 2023 and approximately 4,310 will die from the disease, ...Read more
2024 20 Jan
According to the National Cancer Institute , the incidence of cervical cancer in the United States has been steadily declining in recent decades, from an estimated 11.2 cases per 100,000 women in 1992 to 6.7 cases per 100,000 women in 2019. Statistics from other parts of the world, however, paint a substantially different picture. In the...Read more
2024 16 Jan
Foreword For too long, there has been a one-size fits all approach to women’s healthcare, which does not consider the individual nature of women’s physiological, emotional, socio-economic and practical needs. This has been exacerbated by too few female voices involved in forming policy and health related decision making at the highest...Read more
2023 28 Jun
Cervical cancer is the second most common cancer-related deaths among women in India. In 2020, India accounted for 21% of new cases of cervical cancer and 23% of deaths due to cervical cancer in the world. India has been facing a significant burden of cervical cancer cases, making it one of the countries grappling with a high number of new cases and...Read more
2023 13 Jan
Researchers from UC Davis Comprehensive Cancer Center found that a large number of women aged 65 and older, in the Californian region, are facing late-stage cervical cancer diagnoses. The alarming number emerges in spite of guidelines that advise women to stop cervical cancer screening at this age. The findings underline the need to look at...Read more
2022 05 Dec
A new study, authored by experts from the University of Illinois Chicago, the University of California San Francisco and the U.S. Centers for Disease Control and Prevention, found that women over the age of 65 may be undergoing unnecessary cervical cancer screenings. The study looked at Medicare claims data between 1999 to 2019 for fee-for-service...Read more
2022 13 Jul
Hologic has partnered with other forward-thinking organizations to drive change that will impact women's lives for generations. This includes ALL women, regardless of race, caste or creed. Statistics show that Hispanic women are 40% more likely to be diagnosed with cervical cancer and 30% more likely to die from it than non-Hispanic white women....Read more
2022 14 Jan
The International Agency for Research on Cancer (IARC) as well as the U.S. Congress marks January as Cervical Cancer Awareness Month. The U.K also recognizes 17-23 January 2022 as Cervical Cancer Prevention Week. Over 14,000 U.S. women are diagnosed each year. Globally, it was estimated in 2018 that cervical cancer caused 311,000 deaths making...Read more
2021 05 Nov
New research, funded by Cancer Research UK and published in The Lancet, found 87% lower cervical cancer rates in English women who were offered the Cervarix human papillomavirus (HPV) vaccine vaccinated at ages 12 and 13 than unvaccinated women of similar age. This study provides the first direct evidence of Cervarix‘s effectiveness in lowering cervical...Read more
2021 02 Aug
Women are often the first line of defense when protecting their family’s health, but in doing so tend to put their concerns on the back burner. While ageing is a topic of concern for most women, few take the time to focus on themselves. Studies have proven that following these top health tips will extend and improve women’s lives expodentially, according...Read more
2021 05 Jul
According to the CDC’s National Breast and Cervical Cancer Early Detection Program, breast cancer screenings for underserved women decreased by 87%, and by 84% for cervical cancer, during April 2020 when compared to the previous five years of averages for the month. In a statement, lead study author and CDC health scientist Amy DeGroff said...Read more
2017 16 Sep
Hologic, Inc. is deeply concerned that the United States Preventive Services Task Force (USPSTF) did not include a grade for co-testing (also known as Pap+HPV Together) in draft cervical cancer screening recommendations released this week. These draft recommendations do not consider the wealth of data supporting the value of co-testing, and will put...Read more
2017 29 Apr
Artificial Intelligence (AI) has already exceeded human abilities in several areas. It is expected that soon AI will be used to read biomedical images more accurately than medical personnel alone. This could potentially result in better early cervical cancer detection at much lower cost. See Also : AI Systems 'Augment' Human Diagnosticians...Read more
2016 03 May
Co-testing with Pap+HPV Together™ results in significantly fewer false-negative results than either test used alone 1 A new cervical cancer screening study demonstrates that Pap+HPV Together™ (co-testing) remains the most effective strategy for detecting high-grade cervical lesions 1,2, Hologic, Inc. has announced. The study, published...Read more
2016 02 May
New Data Suggests Nearly Half of Women Neglect to Take Action Against Osteoporosis While nearly three-quarters of Americans (71%) are aware of the effects that osteoporosis can have on their health, only about half report taking any steps to prevent it, 1 according to the results of a new survey has announced by Hologic. To mark the start...Read more
2015 07 Dec
A high-profile conference for Boston-area women will host Marlborough-based Hologic and its 40-foot 3D MAMMOGRAPHY™ bus, a hands-on display of the latest innovation in breast cancer screening. Hologic’s 3D MAMMOGRAPHY™ bus is a walk-through tour and information center for women to learn about a new kind of mammogram, which clinical studies have...Read more
2015 12 Nov
Co-testing could prevent more cases of invasive cervical cancer and cost the health care system less money over time, study shows Researchers presented a new clinical-economic modeling analysis this week showing that screening for cervical cancer with Pap+HPV Together™ (co-testing) using the Aptima® HPV assay (an mRNA-based HPV test) and the...Read more
2015 16 Jul
Hologic, Inc. (NASDAQ: HOLX) has commented on an important cervical cancer screening studyipublished on-line this week in Cancer Cytopathology , a peer-reviewed journal of the American Cancer Society. The study, by researchers at Quest Diagnostics and the University of Pittsburgh Medical Center, supports current consensus guidelinesii for cervical...Read more
2015 17 Sep
Join us for the 30th International Papillomavirus Conference & Clinical Workshop (HPV 2015), to be held September 17-21 in Lisbon, Portugal. This exciting conference will bring together researchers, clinicians and other healthcare professionals in an international forum, enabling the exchange of the latest advances in both science and practice, within...Read more
2015 12 Jan
The Society of Gynecologic Oncology (SGO) and the American Society for Colposcopy and Cervical Pathology (ASCCP) have issued a new interim guidance for cervical cancer screening that recommends the use of a human papillomavirus (HPV) test alone as the primary screen to find cervical cancer or its precursors. At present, such screening is done with either...Read more
2014 14 Nov
Researchers at the University of Wolverhampton, Queen's University of Belfast and Athlone Institute of Technology in Ireland have found that using disulfiram in a vaginal ring could possibly reduce the side effects experienced by cervical cancer patients during treatment. The research has been published in the European Journal of Pharmaceutics and...Read more